Key result
Hypertrophic cardiomyopathy presents a complex clinical spectrum requiring tailored management to relieve symptoms and prevent disease progression, major cardiovascular complications, and sudden cardiac death.
Hypertrophic cardiomyopathy presents a heterogeneous clinical spectrum requiring individualized management to relieve symptoms and prevent sudden cardiac death.
Complex HCM phenotypes warrant tailored echo surveillance; leaves open optimal imaging for SCD risk stratification in asymptomatic patients.
The clinical spectrum of hypertrophic cardiomyopathy (HCM) is complex and includes a variety of phenotypes, which leads to different types of manifestations.Although most of the patients are asymptomatic, a significant proportion of them will develop symptoms or risk of arrhythmias and sudden cardiac death (SCD).Therefore, the objectives of HCM diagnosis and management are to relieve the patients' symptoms (chest pain, heart failure, syncope, palpitations, etc.), prevent disease progression and major cardiovascular complications and SCD.The heterogeneity of HCM patterns, their symptoms and assessment is a challenge for the cardiologist.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a review in Hypertrophic cardiomyopathy (HCM). Hypertrophic cardiomyopathy presents a complex clinical spectrum requiring tailored management to relieve symptoms and prevent disease progression, major cardiovascular complications, and sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: